Drug Reference · Updated 2026-05-08

Zepbound

Brand name for tirzepatide, FDA-approved for chronic weight management and obstructive sleep apnea in adults with obesity.

By Eli LillyUpdated 2026-05-08
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Zepbound overview

Brand name for tirzepatide, FDA-approved for chronic weight management and obstructive sleep apnea in adults with obesity.

Zepbound at a glance

Manufacturer
Eli Lilly
FDA status
FDA-approved

Related pages